Cargando…
The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
Pharmacotherapy for neuropsychiatric disorders, such as anxiety and depression, has been characterized by significant inter-individual variability in drug response and the development of side effects. Pharmacogenetics, as a key part of personalized medicine, aims to optimize therapy according to a p...
Autores principales: | Radosavljevic, Milica, Svob Strac, Dubravka, Jancic, Jasna, Samardzic, Janko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218654/ https://www.ncbi.nlm.nih.gov/pubmed/37239455 http://dx.doi.org/10.3390/genes14051095 |
Ejemplares similares
-
Effects of acute and chronic administration of neurosteroid dehydroepiandrosterone sulfate on neuronal excitability in mice
por: Svob Strac, Dubravka, et al.
Publicado: (2016) -
New tools for neuroenhancement – what about neuroethics?
por: Erhardt, Julija, et al.
Publicado: (2016) -
The serotonergic system and cognitive function
por: Švob Štrac, Dubravka, et al.
Publicado: (2016) -
Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation
por: Ram, Daya, et al.
Publicado: (2015) -
The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats
por: Švob Štrac, Dubravka, et al.
Publicado: (2012)